Eli Lilly
Trade Eli Lilly 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About LLY
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies.
LLY Key Statistics
Stock Snapshot
As of today, Eli Lilly(LLY) shares are valued at $1,180.23. The company's market cap stands at 1.12T, with a P/E ratio of 42.78 and a dividend yield of 0.54%.
During the trading session on 2026-07-14, Eli Lilly(LLY) shares reached a daily high of $1,196.25 and a low of $1,166.01. At a current price of $1,180.23, the stock is +1.2% higher than the low and still -1.3% under the high.
Trading volume for Eli Lilly(LLY) stock has reached 2.07M, versus its average volume of 2.75M.
The stock's 52-week range extends from a low of $623.78 to a high of $1,249.45.
The stock's 52-week range extends from a low of $623.78 to a high of $1,249.45.
LLY News
Wall Street brokerage Guggenheim has raised its price target on Eli Lilly’s (LLY) stock heading into the company’s second-quarter earnings print, saying weight-...
Prediction: 1 New Reason Eli Lilly Stock Could Still Be Headed Higher By Vandita Jadeja Published Jul 13, 2:00PM EDT Quick Read LLY earns a BUY with a $1,336...
UBS raised the firm’s price target on Eli Lilly (LLY) to $1,425 from $1,250 and keeps a Buy rating on the shares. TipRanks has entered a new arena in the inves...
Analyst ratings
84%
of 31 ratingsMore LLY News
Eli Lilly and Company (NYSE:LLY) shares are in the spotlight Monday as the company presents new data at the Alzheimer’s Association International Conference in...
Eli Lilly (LLY 2.30%) commands a market capitalization of about $1.06 trillion, and that valuation was built largely on two drugs: Mounjaro and Zepbound. Invest...
Key Points Lilly's business is booming. However, there is a bear case against the pharma stock. One smart strategy could be to gradually build a position in...
Eli Lilly's eczema drug Ebglyss received a positive recommendation from Canada's Drug Agency, supporting future public reimbursement. The company agreed a new...
Eli Lilly And Company (LLY) announced an update on their ongoing clinical study. TipRanks has entered a new arena in the investing world, powering the index of...
Key Points More Americans than ever are using GLP-1 drugs. Eli Lilly recently rolled out an oral weight loss drug. 10 stocks we like better than Eli Lilly ›...
Eli Lilly’s $400 Billion Surge Is Reshaping Big Pharma By Chris MacDonald Published Jul 9, 2:28PM EDT Quick Read LLY added $400 billion in market value over o...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.